Clinical trial ALTAIR
A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cell Lung Cancer (ALTAIR)
| Cancers | |
|---|---|
| Organ | Lung |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | AstraZeneca |
| EudraCT Identifier | 2024-519786-22-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06996782 |
| Last update |